1004523-72-1 |
VRX-806 |
化合物 T34275 |
C24H18BrClN4O3S |
557.84672 |
1799733-53-1 |
Voxilaprevir intermediate4 |
Voxilaprevir intermediate4 |
C13H21NO4 |
255.31 |
851671-74-4 |
Voxilaprevir intermediate1 |
(2S,3S,4R)-3-乙基-4-羟基-1,2-吡咯烷二甲酸二叔丁酯 |
C16H29NO5 |
315.41 |
719301-50-5 |
Vidofludimus methyl ester |
VIDOFLUDIMUS METHYL ESTER |
C21H20FNO4 |
369.39 |
136272-13-4 |
1-vinyl-1,2,3,4-tetrahydronaphthalene |
1-vinyl-1,2,3,4-tetrahydronaphthalene |
C12H14 |
158.24 |
86150-60-9 |
Valaciclovir Ep Impurity F |
伐昔洛韦EP杂质F |
C7H15NO3 |
161.2 |
1815608-51-5 |
Vortioxetine impurity S |
沃替西汀杂质S |
C18H22N2S |
298.45 |
2092923-21-0 |
VU 6008667 |
VU 6008667 |
C24H17ClF2N2O2 |
438.85 |
148798-88-3 |
Valeric acid 4-Vinylphenyl Ester |
Valeric acid 4-Vinylphenyl Ester |
C13H16O2 |
204.26494 |
1393344-72-3 |
varlilumab |
伐立鲁单抗 |
|
0 |